Genomic Health ( GHDX) This company is engaged in the development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. This stock is trading up 5.2% at $27.80 in recent trading. Today's Volume: 468,000 Average Volume: 215,905 Volume % Change: 221% From a technical perspective, GHDX is bouncing sharply higher here off some near-term support at $25.25 with above-average volume. This bounce is coming after shares of GHDX recently gapped down big from $32 to $25.25 with heavy volume. That gap down has pushed GHDX into modestly oversold territory, since its current relative strength index (RSI) reading is 33.15. Traders should now look for long-biased trades in GHDX once it manages to break out above its gap down day high near $29 with high volume. Look for a sustained move or close above $29 with volume that hits near or above 215,905 shares. If that breakout triggers soon, then look for GHDX to re-fill some of that gap back towards $31 to $32 in the near future. On the flipside, I would look for short-biased trades if GHDX fails to trigger that breakout, and then drops below $25.25 with heavy volume. Affymax ( AFFY) This is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. This stock is trading up 8.5% at $23.17 in recent trading. Today's Volume: 1.47 million Average Volume: 875,894 Volume % Change: 143% From a technical perspective, AFFY is ripping dramatically higher here right off some near-term support at $20.82 and back above its 50-day moving average of $22.17 with monster volume. This move is quickly pushing AFFY within range of triggering a near-term breakout trade. That trade will hit once AFFY manages to take out some near-term overhead resistance at $24 with high volume. Traders should now look for long-biased trades in AFFY as long as it's trending above its 50-day at $22.17, and then once it sustains a move or close above $24 with volume that hits near or above 875,894 shares. If that breakout triggers soon, then AFFY will set up to re-test or possibly take out its next major overhead resistance levels at $26.14 to $27.74. Any high-volume move above $27.74 should be considered bullish technical price action, since that will mean AFFY has entered new 52-week high territory.